SUPRADYN Vital 50+ cpr eff bte 30 pce
7680572880014
CH-57288
A11AA03
07.02.52
1 / 3
google
Details
- Product number
- 5728802
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- retinoli palmitas 1333 U.I., thiamini hydrochloridum 2.1 mg ut monophosphothiamini chloridum, riboflavinum 2.4 mg ut riboflavini natrii phosphas, nicotinamidum 18 mg, acidum pantothenicum 6 mg ut calcii pantothenas, pyridoxini hydrochloridum 3 mg, biotinum 75 µg, acidum folicum 300 µg, cyanocobalaminum 1.5 µg, acidum ascorbicum 90 mg, cholecalciferolum 200 U.I., RRR-alpha-tocopherolum 15 mg ut int-rac-alpha-tocopherylis acetas, ginseng extractum siccum 50 mg, calcium 160 mg ut calcii carbonas et calcii glycerophosphas et calcii pantothenas, magnesium 120 mg ut magnesii hydrogenophosphas trihydricus et magnesii oxidum ponderosum, cuprum 1 mg ut cupri(II) d-gluconas, iodum 60 µg ut kalii iodidum, ferrum 5.6 mg ut ferrosi lactas dihydricus, manganum 1.4 mg ut mangani sulfas monohydricus, selenium 28 µg ut natrii selenis, zincum 6 mg ut zinci citras trihydricus, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, maltitolum 168.56 mg, sorbitolum 353.92 mg, povidonum K 30, polysorbatum 60, crospovidonum, mannitolum, polysorbatum 80, simeticonum, sacchari monopalmitas, E 162, E 160(a), cocois oleum, maltodextrinum, acaciae gummi, saccharum 7.27-9.02 mg, E 301, silica colloidalis anhydrica, E 307, natrii chloridum, aspartamum 40 mg, acesulfamum kalicum, aromatica (Orange), aromatica (Passionsfrucht), natrii citras dihydricus, gelatina, maydis amylum, sojae oleum partim hydrogenatum 0.18 mg, amylum modificatum, pro compresso corresp. natrium 227 mg.
Articles (1)
Supradyn Vital 50+, Brausetabletten
Brausetabletten
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1333.0 UI | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.1 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
2.4 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
18.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
75.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
300.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
1.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
90.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
200.0 UI | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
5.6 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
1.4 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
28.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
168.56 MG | Substance | HBESI |
|
(N/A)
|
353.92 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTON |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
40.0 MG | Substance | AIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.18 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
227.0 MG | Substance | HBESI |
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 57288
- Drug name
- Supradyn Vital 50+, Brausetabletten
- Galenic form
- BRAT
- ATC Code
- A11AA03
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 15/07/2005
- Authorization expiration date
- 31/12/9999
- IT number
- 07.02.52
- Domain
- Human medicine
Packaging details
- Description (FR)
- SUPRADYN Vital 50+ cpr eff bte 30 pce
- Description (DE)
- SUPRADYN Vital 50+ Brausetabl Ds 30 Stk
- Market launch
- 27/05/2016
- Narcotic (BTM)
- No